Summary
PP10, a new placental glycoprotein, was studied by a specific and sensitive double-antibody radioimmunoassay in maternal serum and other body fluids throughout pregnancy. The mean value of serum PP10 in healthy nonpregnant individuals was approximately 10 μU/l. During normal pregnancy it rose to 3,500 μU/l. The rate of rise was obtained from 78 normal pregnancies with 279 single assay values from weeks 6–40. The shape of the curve resembled that for other placental proteins (HPL, SP1). PP10 levels in amniotic fluid were measured in 145 samples from weeks 13–55 of normal pregnancies and at term. The mean concentration was 500 μU/l until week 18 and then rose slowly. Cord blood contained only trace amounts. PP10 was not found in maternal urine. The concentration in maternal serum and amniotic fluid was higher in twin pregnancies than in singleton pregnancies. In 46 cases with low birth weights the PP10 levels in maternal serum were significantly lower than normal. Simultaneous measurements of PP10 and E3, HPL and SP1 were made in 17 individual follow-up's. PP10 was comparable with E3 and appeared to be better than HPL and SP1 in predicting intrauterine fetal growth retardation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baur MP, Bellmann O, Tebbe J, Lang N (1982) Concentrations of placental proteins (HPL and SP1) in maternal serum throughout normal pregnancy. Arch Gynecol 231: 153–158
Bohn H, Kraus W (1979) Isolierung und Charakterisierung eines neuen plazentaspezifischen Proteins (PP10). Arch Gynecol 227: 125–134
Bohn H, Inaba N, Lüben G (1981) New placental proteins and their potential diagnostic significance as tumour markers. Oncodev Biol Med 2: 141–153
Geiger W (1974) Radioimmunologische Bestimmungen von HCG, HCS, STH und TSH. Fortschr Geb Gynäkol 52: 1–120
Hytten FE, Leitch J (1971) The physiology of human pregnancy. Blackwell Scientific, Oxford
Inaba N, Renk T, Ax W, Schottler S, Weinmann E, Bohn H (1981) Possible synthesis of pregnancy-“specific” beta-1-glycoprotein (SP1) and placenta-“specific” tissue proteins (PP10, PP12) by human and cynomolgus monkey leucocytes. Acta Haematol (Basel) 66: 35–38
Inaba N, Renk T, Bohn H (1980) Immunohistochemical location of placental proteins (PP8, 9, 10, 11, 12) in human term placentae. Arch Gynecol 230: 109–121
Inaba N, Renk T, Wurster K, Rapp W, Bohn H (1980) Ectopic synthesis of pregnancy-specific β1-glycoprotein (SP1) and placenta-specific tissue proteins (PP5, PP10, PP11, PP12) in nontrophoblastic malignant tumours. Possible markers in oncology. Klin Wochenschr 58: 789–791
Künzig HJ, Geiger W (1974) Radioimmunological determination of plasma unconjugated estriol in normal and abnormal pregnancies with a specific antiserum to estriol. Arch Gynecol 216: 387–398
Lubchenco LO, Hansmann C, Dressler M, Boyd E (1963) Intrauterine growth as estimated from liveborn birthweight data at 24 to 42 weeks of gestation. Pediatrics 32: 793–800
Marchalonis JJ (1969) An enzymatic method for the trace labelling of immunoglobulins and other proteins. Biochem J 113: 299–305
Würz H, Geiger W, Künzig HJ, Jabs-Lehmann A, Bohn H, Lüben G (1981) Radioimmunoassay of SP1 (pregnancy-specific β1-glycoprotein) in maternal blood and in amniotic fluid in normal and pathologic pregnancies. J Perinatol Med 9: 67–78
Würz H, Lüben G, Bohn H (1982) Placental proteins PP10 and PP12 in breast cancer and genital cancer. Cancer Detect Prev 5: 253–254
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Würz, H., Lüben, G., Bohn, H. et al. Concentration of placental protein 10 (PP10) in maternal serum and amniotic fluid throughout normal gestation and in pregnancy complicated by fetal growth retardation. Arch. Gynecol. 233, 165–174 (1983). https://doi.org/10.1007/BF02114597
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02114597